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HOW SAFE IS OUR FOOD?
Lessons from an Outbreak of Salmonellosis
THE microbiologic hazards of food present an issue
of increasing concern.1,2 In the not-so-distant past, most
food was produced and consumed locally. In the 20th
century, however, the production and distribution of
food in the developed countries of the world have become increasingly industrialized. Small farms are being
replaced by feedlots, local dairies supplanted by industrial plants, farmers’ markets displaced by supermarkets, and local restaurants edged out by huge national
chains. The relations among agricultural workers, food
processors, and distributors have become increasingly
complex and distant. The food chain and steps in food
production are being varied in ways that stretch the
imagination. From an economic standpoint, modern
agribusiness offers many beneﬁts, including the wide
choices and apparently low costs of food available to
the consumer. The development of national standards
has improved food safety, yet certain microbial pathogens persist, the scale of foodborne transmission is increasing, and new hazards are being recognized. Many
of these phenomena are exempliﬁed in this issue of the
Journal, in the clear and comprehensive report by Hennessy and colleagues of a massive outbreak of salmonellosis.3
Salmonellosis — with the notable exception of typhoid fever — is a disease of civilization. The animals
we use for food production frequently carry salmonella,
thus contaminating meat, dairy products, and eggs.4
Salmonellosis is rare in developing countries, where
sanitation is poor and diarrheal diseases are endemic,
but where food production and consumption are local.5
In contrast, in the United States the reported incidence
of salmonellosis has been increasing over the past 50
years,6 and approximately 1 percent of the population
becomes infected each year.7 Outbreaks are becoming
larger and, as shown by Hennessy and coworkers, may
affect hundreds of thousands of people.
Most cases of salmonellosis (and foodborne illness)
are considered to be endemic (or sporadic) because they
are not clustered. The usual explanation for endemic
cases is the inappropriate handling in kitchens and restaurants of contaminated food (including improper
storage, undercooking, or cross-contamination). This is
a plausible hypothesis because so many of the farm animals in the United States are colonized with salmonella and products derived from these animals subsequently become contaminated. Alternatively, sporadic
cases of disease may occur when a widely distributed
food has low levels of contamination, a situation that
leads to a low attack rate diffusely distributed over a
large geographic area, so that no one realizes that an
epidemic is occurring. The investigation by Hennessy
and colleagues3 illustrates this second pattern. Despite
substantial publicity, fewer than 600 of the more than
200,000 estimated cases of salmonellosis in this outbreak (only 0.3 percent) were actually reported to public health departments. The epidemic both highlights
the deﬁciencies in our nationwide system of passive sur-
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veillance for salmonellosis7 and illustrates the value of
ﬁeld epidemiology that uses current surveillance data
to detect outbreaks and prevent further transmission
and disease. The cooperation of state and federal agencies and the speed with which they worked to solve the
puzzle and protect the public safety make this a model
for future investigations.
However, this epidemic probably reﬂects only the tip
of the iceberg. The low surveillance rate suggests that
smaller outbreaks are regularly missed. That the incidence of salmonellosis among persons with AIDS is
many times that among the general public8 is also consistent with the view that widely distributed foods are
contaminated by low doses of a pathogenic agent, leading to low attack rates in normal hosts but higher rates
in compromised hosts.9 Such sentinel populations teach
us much about the distribution of particular agents.
This model also may be applicable to other foodborne
illnesses, in which detection of the agent and surveillance are even less efﬁcient than for salmonella. The
high incidence of Campylobacter jejuni infections in persons infected with the human immunodeﬁciency virus10
points to the widespread transmission of low levels of
this foodborne agent as well.
Modern food production is often so complex that
many points at which contamination could occur are
simply not recognized. Thus, in the outbreak of salmonellosis the use of tanker trailers to ship both pasteurized and nonpasteurized products represents a classic cross-connection that was not identiﬁed until the
investigation was undertaken. The bulk transport of
nonpasteurized liquid eggs provides an efﬁcient means
of amplifying the impact of even a single salmonellacontaminated egg11 so that it affects large numbers
of consumers. This outbreak underscores the fact that
to minimize risk from unrecognized hazards, pasteurization — one of the most powerful tools against bacterial pathogens in the public health armamentarium —
should be undertaken at the latest possible step in food
production.
Manifestations of foodborne disease are not restricted to the gastrointestinal tract, as illustrated by the
etiologic role of Escherichia coli O157:H7 in the hemolytic–uremic syndrome,1 C. jejuni in Guillain–Barré syndrome,12 and Listeria monocytogenes in fetal morbidity,13
nor are the ramiﬁcations always obvious. The most
pernicious threat may be the spread of antibiotic resistance by foodborne organisms,14 because of the promiscuous use of subtherapeutic doses of antibiotics as food
supplements for farm animals, or the potential foodborne spread of the scrapie agent. New opportunities
for foodborne diseases result from the increasing internationalization of our food supply, with the importation
of foodstuffs from all parts of the globe, the introduction of new and sometimes uncooked items into our
diets, and the preparation of food in restaurants and
households by people who may be carrying unusual
pathogens.6,15
Food is not sterile, and eating cannot be made riskfree. Because of the standardization and quality-control
measures that are part of industrialized food produc-
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tion, the safety of our food from many microbial hazards has probably never been greater. Yet because of
the potential for ampliﬁcation of a pathogen that is
implicit in large-scale food production, the opportunities for the foodborne transmission of disease seem to
be increasing. The grim implications of bovine spongiform encephalopathy (mad-cow disease) for cattle and
possibly humans point to the unanticipated problems
that can arise from a breach in basic ecologic relations
(cows, which are herbivores, were fed animal offal).
Since new hazards are emerging from both familiar
pathogens such as salmonella and previously unrecognized microbial threats, improved surveillance for foodborne infections is essential. Careful medical detective
work similar to that reported by Hennessy et al.3 should
highlight the basic ecologic imbalances underlying endemic and epidemic foodborne hazards and lead to their
correction.
Vanderbilt University
School of Medicine
Nashville, TN 37232-2605

MARTIN J. BLASER, M.D.
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EXERCISE FOR WOMEN — HOW MUCH PAIN
FOR OPTIMAL GAIN?
REGULAR physical activity is important for health
and has been linked to a reduced risk of numerous
chronic diseases.1 Nonetheless, fewer than half of American adults engage in regular exercise.2 A recent federal
recommendation regarding regular exercise3 was based
on three major considerations: the potential health beneﬁts, safety, and feasibility of different amounts and intensities of physical activity. This recommendation applies to both men and women, but safety is particularly
relevant to women, since exercise of high intensity and
long duration may lead to menstrual and reproductive
dysfunction. Given the potential differences between
men and women in the balance of the beneﬁts and the
risks of exercise, what should the optimal guidelines be
regarding physical activity for women?
The recent recommendations regarding exercise from
the Centers for Disease Control and Prevention and
the American College of Sports Medicine encourage 30
minutes of moderately intense physical activity on most,
and preferably all, days of the week.3 This contrasts with
previous recommendations that generally endorsed vigorous endurance exercise (i.e., at a level that results in
a heart rate 60 to 90 percent of the maximal rate) for
at least 20 minutes three times a week.4 The earlier recommendations were based on physiologic data showing
that such a regimen induced cardiorespiratory ﬁtness in
untrained or previously sedentary people. The recent

and less formidable recommendation was designed, in
part, to present less of an obstacle to exercise in the
predominantly sedentary U.S. population. Unfortunately, many have interpreted the new recommendation as
superseding previous guidelines and as meaning that
high-intensity exercise offers no additional beneﬁt over
physical activity of moderate intensity. This is a misinterpretation. In fact, the recent guidelines state that
“the recommendation presented . . . is intended to
complement, not supersede, previous exercise recommendations,” and “people who already meet the recommendation are also likely to derive some additional
health and ﬁtness beneﬁts from becoming more physically active.”
In this issue of the Journal, Williams5 provides evidence supporting the latter statement by documenting
a dose–response relation for plasma high-density lipoprotein (HDL) cholesterol concentrations among women runners. HDL cholesterol levels increased with increasing numbers of kilometers run, even beyond 64
km per week. Should we then recommend a maximal
intensity and amount of physical activity for women?
Before we reach this conclusion, the issues of efﬁcacy,
safety, and feasibility must be carefully weighed.
The available data indicate that physical activity is
associated with numerous beneﬁts in terms of health,
including a lower incidence of cardiovascular disease,
non-insulin-dependent diabetes mellitus, osteoporotic
fractures, colon cancer, and perhaps breast cancer.1 Regular physical activity also helps to maintain a healthy
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body weight, thus reducing the incidence of diseases related to obesity.1
On the other hand, if extreme loss of weight and
body fat results from regular exercise, amenorrhea may
occur.1,6 Sustained alterations in the levels of female reproductive hormones have been observed with intense
exercise training.1,6 In female athletes who increase their
running mileage, levels of progesterone in the midluteal
phase are lower during the cycles in which mileage is
increased; in addition, the luteal phase may be shortened, with or without prolongation of the follicular
phase. If the hormonal dysfunction progresses, anovulation may follow, initially in the presence of normal
estrogen levels; later, hypoestrogenic amenorrhea may
occur. Infertility is also more likely to occur among
female athletes in whom such reproductive-system dysfunction develops.1,6 Because of the integral role of
estrogen in maintaining bone mass, osteoporosis is another concern in women with menstrual dysfunction.1
Female athletes with amenorrhea have lower bone mineral density than their counterparts with normal menstrual patterns who follow the same exercise regimens.
When female athletes resume normal menses, they regain some bone mass, but bone density may still be
lower than in athletes who have continued to have normal menses. In addition to amenorrhea and osteoporosis, eating disorders (including anorexia nervosa and
bulimia nervosa) may occur, especially among adolescent and young adult female athletes involved in activities in which thinness is perceived to have aesthetic
value, such as ballet and gymnastics.7 This combination of medical disorders, termed the “female-athlete
triad,” has been an increasing source of concern to experts in sports medicine.
With high intensities and large amounts of physical
activity, musculoskeletal injuries are another potential
mechanism of adverse effects on health. The available
data regarding injuries associated with different types
of physical activity are limited. Running has been studied the most; the risk appears to be fairly substantial,
with 35 to 65 percent of runners injured per year.1
There also appears to be a direct relation between the
risk of musculoskeletal injury and the distance run per
week. Moreover, in those who have habitually been sedentary, the initiation of vigorous exercise may substantially increase the risk of acute myocardial infarction;
this is especially true for older persons.8
The study by Williams does not allow us to evaluate
the balance of beneﬁts and risks of higher amounts and
intensities of physical activity. Speciﬁcally, it does not
provide information on the prevalence of menstrual irregularities (we know only the percentage of the women who reported still having periods), bone mineral
density, or the frequency of musculoskeletal injuries. It
would have been helpful to examine whether these adverse health effects increase in frequency with increasing distance run per week.
Evidence from other sources indicates, however, that
the risks of reproductive and musculoskeletal problems
associated with high-intensity physical activity exceed
those associated with moderate physical activity; thus,
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it is of particular importance to compare the relative
beneﬁts of high-intensity and moderate-intensity exercise. The data that are available demonstrate that a
moderate amount of physical activity at a moderate intensity confers important health beneﬁts. In a study of
more than 3000 women 20 years of age or older who
were followed for eight years, Blair et al. reported an
inverse association between physical ﬁtness and death
from any cause.9 The greatest reduction in mortality occurred between the lowest and the second-lowest quintiles of the group in terms of physical ﬁtness. As compared with women in the least-ﬁt quintile, those in the
second-least-ﬁt quintile were 48 percent less likely to
die during follow-up. With increasing levels of physical
ﬁtness, mortality continued to decline, although the incremental gains were smaller; women in the most-ﬁt
quintile were 78 percent less likely than the least ﬁt to
die during follow-up. Among 73,029 women in the Nurses’ Health Study who were 40 to 65 years of age at base
line and were followed for four years, the level of physical activity was inversely related to the incidence of
both coronary heart disease and stroke.10 Again, the
largest reduction in risk occurred between the lowest
and the second-lowest quintiles with respect to physical
activity; even brisk walking was associated with a substantial reduction in risk.
With regard to feasibility, given the high prevalence
of sedentary lifestyles among adult Americans — some
60 percent perform no regular physical activity, or only
irregular physical activity2 — it is unrealistic to expect
that this nation will cheerfully embrace an exercise regimen that involves long periods of intense physical activity, whatever the beneﬁts in terms of health. The recent recommendation that adults engage in 30 minutes
of moderately intense physical activity, such as brisk
walking, on most days of the week represents a more
feasible goal. Moreover, physical activity at moderate
intensity has fewer health risks than vigorous activity,
especially for those who have previously been sedentary.8 We do not mean to discount the additional health
beneﬁts that may accrue with more frequent, longer,
and more intense physical activity, and we would not
dissuade those who wish to exercise more. We do believe, however, that at some point the risks outweigh
the health beneﬁts of increased physical activity. If
amenorrhea, reproductive disorders, or repeated musculoskeletal injuries occur, we believe that the level of
exercise that produces these complications is excessive,
regardless of its health beneﬁts.
Harvard Medical School and
School of Public Health
Boston, MA 02115

I-MIN

JOANN E. MANSON,
M.D., DR.P.H.
LEE, M.B., B.S., SC.D.
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DIVERSITY IN MEDICINE
WITH a record number of applicants to medical
schools in the United States in 1995 and concern about
a surplus of physicians, it is sometimes forgotten that
many people are underserved by the medical profession, particularly the poor, members of minority groups,
and residents of rural areas. Although the underserved
are less likely to have health insurance or other ﬁnancial resources, they are more likely to have medical
needs. These needs may be aggravated by social or ﬁnancial problems, language barriers, or inability to ﬁnd
high-quality care.
In this issue of the Journal, Komaromy et al. document the essential role of minority physicians in California in caring for the poor and members of minority
groups.1 The ﬁndings are striking and are consistent
with the results of other studies.2,3 At a time when college and university admissions policies that give preference to members of minority groups are under attack
throughout the country, such data are particularly relevant. In July 1995, the regents of the University of
California banned preference based on race or sex in
admissions, hiring, and contracting.4 In March 1996,
the U.S. Court of Appeals for the Fifth Circuit sharply
limited the use of afﬁrmative-action programs at the
University of Texas.5 And in November 1996, Californians will vote on the California Civil Rights Initiative,
a measure that would ban race- and sex-based preferences in public employment, public education, and public contracting. Thus, although there is strong support
within the medical profession for increasing racial, ethnic, and sexual diversity among physicians,6,7 in the
near future fewer members of minority groups may enter medical practice.
Using various sources of information and a survey of
physicians, Komaromy et al. examined the relation between the characteristics of physicians in California
and the communities where they practice. Communities
with high proportions of black and Hispanic residents
were substantially more likely than other areas to have
shortages of physicians, regardless of community income. On average, black and Hispanic physicians practiced in areas with fewer primary care physicians per
capita than did white physicians. These areas tended to
have higher proportions of residents with the same racial and ethnic background as the physicians. Even after taking the proportions of such residents into ac-

count, Komaromy et al. found that black and Hispanic
physicians cared for substantially more black and Hispanic patients, respectively, than did other physicians.
Black physicians cared for more patients with Medicaid
insurance, and Hispanic physicians cared for more patients without health insurance.
These ﬁndings are supported by national data from
the Association of American Medical Colleges.8 In
1993, 39.8 percent of students graduating from medical
school who were members of underrepresented minorities (blacks, Mexican Americans, mainland Puerto
Ricans, and American Indians) said they planned to
practice in underserved areas, as compared with 8.9
percent of other graduates. Nearly 60 percent of members of underrepresented minorities preparing for careers as generalists planned to locate in such areas, as
compared with less than 24 percent of other graduates
preparing for generalist careers.
Komaromy et al. cite studies showing that black and
Hispanic patients have less access to care, poorer-quality care, and worse outcomes than non-Hispanic whites.
Their ﬁndings are limited, however, by the absence of
data on case mix or the quality of care. People who
identify a nonwhite physician as their usual source of
care are likely to be sicker than people who identify a
white physician.3 All other factors being equal, we do
not know whether racial and ethnic congruence between physician and patient is associated with better
care. We do know that patients sometimes prefer physicians with backgrounds similar to their own.
In recent years, more members of underrepresented
minority groups have applied to medical school, entered, and graduated. In 1994, a record 2487 blacks,
Hispanics, and Native Americans (12.9 percent of all
entrants) entered allopathic and osteopathic schools,
and 1495 (8.6 percent of all graduates) graduated.9 In
addition, about 15 percent of graduates were Asians or
Paciﬁc Islanders.8 Between 1990 and 1994, 5 of the 10
medical schools with the highest percentage of underrepresented-minority graduates were in California — at
the University of California campuses at San Francisco,
Davis, San Diego, and Irvine and at Stanford.10 (The
other ﬁve were at Meharry, Morehouse, Howard, the
University of Illinois, and the University of Michigan.)
Nonetheless, as Rivo and Kindig wrote in a recent issue
of the Journal,9 increased minority enrollment in medical schools “is far from enough even to approach a goal
of parity with the minority population in the next 50
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years, given the expected growth of that population.”
Indeed, non-Hispanic whites will represent a decreasing percentage of the U.S. population according to census projections, falling from 76 percent in 1990 to 72
percent in 2000 and 60 percent in 2030.11
In education, fostering diversity can be a win–win
situation, improving both the institution and the educational experience. We learn from people with different
backgrounds and beliefs. A recent federal review of afﬁrmative-action programs at the University of California at Berkeley found that as the campus became more
diverse, the academic quality of the students also increased.12 Physicians are teachers of their colleagues
and role models for future physicians. A diverse physician work force should help us attract people of all races and backgrounds who have outstanding personal
characteristics, genuine motivation to be primary care
physicians, and the skills needed to work in underserved areas, such as ﬂuency in a language other than
English and an understanding of the cultural and health
beliefs of diverse groups. Strong academic performance
and excellent training are essential, but they are not
ends in themselves. Nonetheless, when there are many
applicants for a limited number of spaces, any classiﬁcation system will be perceived as unfair to some.
In the 1970s, Allan Bakke, who is white, claimed that
he had been denied admission to the medical school at
the University of California at Davis because of a quota
system that reserved places in the entering class for
members of minority groups. In 1978, the Supreme
Court, in a ﬁve-to-four vote, found programs that set
aside a ﬁxed number of places for minorities unconstitutional, but said that colleges and universities could
consider race or ethnicity as a factor in admissions decisions.13 In 1995, however, the University of California
regents ended the consideration of race or ethnicity,
even as one factor among many. In the 1995 Adarand
case, the Supreme Court sided with a white contractor
in Colorado who had been passed over for a federal
highway contract, despite having submitted the low bid,
because of ﬁnancial incentives to hire minority-owned
ﬁrms.14 Justice Sandra Day O’Connor, writing for the
ﬁve-to-four majority, concluded that racial classiﬁcations imposed by federal, state, or local governments
“are constitutional only if they are narrowly tailored
measures that further compelling government interests.” In the 1996 Hopwood case, the Court of Appeals
for the Fifth Circuit, citing recent Supreme Court rulings, rejected any consideration of race or ethnicity as
a factor in admission to the University of Texas law
school, “even for the wholesome purpose of correcting
perceived racial imbalance in the student body.”5 Although the immediate effects of this controversial decision are limited — the ruling was stayed in April pending an appeal by Texas — this or another case may lead
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the Supreme Court to reconsider the role of afﬁrmative
action in higher education.
As the debate over afﬁrmative action continues, we
should pursue a variety of efforts to diversify the medical work force and increase the number of physicians
who care for the underserved. There are ongoing initiatives to draw academically qualiﬁed minority applicants
to medical schools, such as magnet health-sciences high
schools, science-education partnerships between academic health centers and school systems, and other educational improvements.6 Admissions decisions should
take into account career plans, interest in primary care,
prior community service, language skills, and other relevant factors. We should be concerned that highly qualiﬁed minority applicants may perceive themselves to be
unwelcome at institutions that scale back their commitment to diversity, particularly institutions that have
historically admitted few members of minority groups.
Medical schools should work hard to counter such
perceptions. Adequate ﬁnancial-aid programs are important. Targeted ﬁnancial incentives for practicing physicians would encourage more to care for the underserved.9 Large managed-care ﬁrms are likely to provide
care for an increasing number of minority patients, including Medicaid patients. Such ﬁrms should use some
of their ample ﬁnancial resources to support efforts to
increase the number of minority physicians. In the long
run, universal health insurance, although it is not currently on the horizon, might make the most sense for
the underserved.9 Regardless of the fate of afﬁrmativeaction programs in medicine, the social problems they
are trying to address are not going to go away.
ROBERT STEINBROOK, M.D.
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THE POLITICS OF HUMAN-EMBRYO
RESEARCH — AVOIDING ETHICAL
GRIDLOCK
IN late January 1996, President Bill Clinton signed a
continuing resolution to keep the government open.
Among other things, the resolution prohibits the use of
federal funds for research on human embryos.1 This
prohibition, which continues until September 30, the
end of the current ﬁscal year, would become permanent
if Congress reafﬁrms it and the President concurs.1
Compromise language to limit the prohibition to embryos created expressly for research purposes, but permitting federally funded research on “spare” embryos
(those created for procreation but no longer needed)
was defeated.2 A much stronger case can be made for
using spare embryos in research than for creating embryos speciﬁcally for that purpose. We think that if this
case is made, the compromise language has a reasonable chance of success, should Congress reconsider the
issue.
Compromise, however, requires disentangling the
subject of research on embryos from the continuing debate on abortion. This is so because abortion is a deﬁning political issue, and neither the Supreme Court’s
1992 reconﬁguration of Roe v. Wade3 nor the election of
President Clinton has dethroned it. But abortion is
about more than politics; it is fundamentally about ethics, morals, equality, and religion, and how we think
about abortion reveals much about how we are likely to
think about other life-and-death issues in contemporary
American medical practice. Because politics as currently practiced seems so unprincipled, there have been sporadic attempts to redeﬁne abortion-related issues as
ethical questions and to set up national panels and advisory groups to examine various practices and make
recommendations about their ethics. When the subjects
studied by such panels have been unrelated to abortion,
the panels have often helped to forge a consensus. But
when abortion has dominated the agenda, virtually no
progress has been made.
Even though the abortion debate in the United States
is not likely to be resolved by ethical argument, it
should not be permitted to hold every related issue
of medical ethics hostage, as it now does. Crucial issues such as human-embryo research, prenatal genetic
screening, and the manipulation of embryos before
their implantation must be disengaged from the abortion issue to receive the public debate they require.
This task is extremely complex, as the experience of
the Human Embryo Research Panel of the National Institutes of Health (NIH) shows. It has been more than
18 months since the panel’s report was presented to the
director of the NIH, and it is unlikely that the director
will act on it until the political climate changes substantially. Understanding the content and reasoning of this
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report is critically important to efforts to end the ethical gridlock on abortion-related issues of medical practice and research.
THE HUMAN EMBRYO RESEARCH PANEL
The Human Embryo Research Panel was created to
recommend guidelines for the funding of research on
embryos. It met six times from February to September
1994, when the ﬁnal report was issued.4 The panel’s
narrow charge was to classify potential research involving ex utero human embryos into one of three categories: research acceptable for federal funding, research
warranting additional review, and research unacceptable for federal funding.
By majority vote, the 11 researchers and 8 nonresearchers on the panel (a total of 10 men and 9 women)
concluded that research on methods of improving the
chances of pregnancy; fertilization; egg activation, maturation, and freezing; genetic diagnosis before implantation; and the development of embryonic stem cells
was acceptable for federal funding.4 Research on the
cloning and use of oocytes without their transfer to the
uterus for gestation was considered to warrant additional review. Unacceptable research included the cloning
and use of oocytes followed by transfer, and cross-species fertilization.4
The panel offered speciﬁc guidelines for the review
and conduct of federally funded research. The guidelines stipulated that there be a qualiﬁed researcher and
a valid research design promising major scientiﬁc or
clinical beneﬁt; that the research goals not be accomplishable with animals or gametes; that the number of
embryos required for the research be kept to the minimum necessary to ensure valid results; that informed
consent be obtained from gamete donors; that no gametes or embryos be purchased or sold for use in research; that the research protocol be reviewed by an
institutional review board; that gamete donors be selected equitably; and that no research be conducted on
embryos more than 14 days after fertilization.4
The composition of panels such as this one has been
widely criticized. For example, an earlier NIH panel on
the use of fetal tissue for transplantation research was
criticized by right-to-life groups for including too few
members with explicitly right-to-life views. Others have
said that the Human Embryo Research Panel and earlier panels had too many scientists as members. Feminists have also complained that past embryo-research
panels, such as the Ethics Advisory Board, were made
up almost exclusively of men and had a tendency to
view “embryos and fetuses . . . as a man’s sperm personiﬁed [making them] appear to be real to these men
in a way women are not.”5 The Human Embryo Research Panel was balanced according to sex, but nonetheless there may have been insufﬁcient attention to the
vast differences involved in supplying sperm as compared with ova.
The reason the panel’s recommendations have been
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more or less ignored has little to do with its generally
reasonable conclusions. Rather, in our view, it is because the panel did not make a persuasive moral case
for the conclusions. Unless a strong moral framework is
presented that recognizes and addresses the concern of
those troubled by the use of human embryos for research, such research is unlikely to gain the political acceptance needed for it to receive federal funding.
THE MORAL FRAMEWORK PRESENTED BY THE PANEL
The panel members considered and rejected the view
that a human embryo has rights that completely prohibit its use in research. To those who argue that an
embryo is a human being from the moment of conception, the panel responded that no single trait or property is present at conception that sufﬁces to confer personhood, and thus rights, on the embryo. This view is
persuasive. All human life begins at conception, but
many embryos do not implant, and even among those
that do, many spontaneously abort. Whatever shifts occur in the moral equation at conception, it is not selfevident that that biologic event is of such moral importance that it should cause all human embryos to be
placed outside the realm of research.
Having rejected the idea of innate rights as the
framework for determining the moral status of the human embryo, the panel recommended what it termed a
“pluralistic” approach.4 Embryos, it said, possess “a variety of distinct, intersecting and mutually supporting
considerations,” such as “genetic uniqueness, potentiality for full development, sentience, brain activity, and
degree of cognitive development.” Furthermore, “their
developing presence in an entity increases its moral status until, at some point, full and equal protectability is
required.”4 For those uncertain about the moral status
of human embryos, this was an unsuccessful effort to
please everyone.
Unfortunately, the pluralistic framework — in which
embryos possess a set of properties that somehow,
when mixed in an unexplained and mysterious way,
confer moral standing — is not convincing. This is primarily so because that framework requires a detailed
analysis that explains why the particular properties cited confer moral worth, or to what degree each property cited is necessary or sufﬁcient. Without such an
underlying rationale, the framework looks like an attempt to rationalize a desired conclusion — namely,
that some research on embryos ought to be permitted
— rather than to derive a conclusion from an ethical
analysis.
Such an analysis is needed in order to show that having a unique genetic identity, a nervous system, a human appearance, the potential to become an adult,
brain activity, or the ability to feel pain moves an embryonic entity over the line from being “deserving of respect” to having moral standing such that experimentation would violate its intrinsic rights. Many inanimate
objects, such as cadavers, works of art, national parks,
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and archeological treasures, have moral standing, and
duties of respect are accorded to them in both law and
ethics, but they lack the biologic properties mentioned
by the panel. Likewise, many forms of animate life —
among them, dogs, rodents, pigs, goats, and primates
— are routinely used for research, but they would not
be considered acceptable subjects for experimentation
if the panel’s standards of moral worth were applied to
them. Without knowing why certain properties count,
we cannot draw clear boundaries between acceptable
and unacceptable types of research. From a pluralistic
perspective, we cannot tell whether it is right to prohibit research after the primitive streak appears at 14 days’
development. Why should research on older embryos
not be allowed, if it would beneﬁt other embryos, fetuses, children, or adults?
Inability to deﬁne the moral status of the embryo
convincingly is the crucial failure of both the panel’s report and the overall debate on the subject. Until it is
demonstrated that embryos are owed moral consideration, concern about the ethics of research on embryos
can be dismissed as “nothing more than ﬁghts over
symbols.”6 However, such curt dismissals completely
fail to respond to the deep moral reservations about
such research held by many Americans, including the
President. By adopting a bald political compromise on
a moral issue, the panel guaranteed that its report
would have no effect.7
CREATING EMBRYOS FOR RESEARCH
The need for a moral argument is most vividly demonstrated by the question of whether to allow embryos
to be created solely for research. A recommendation in
favor of this idea was publicly rejected by President
Clinton in December 1994 and probably eroded whatever public support the report might otherwise have received.8 As subsequent congressional action has clearly
indicated, anyone who recommends federal funding for
research on embryos has the burden of persuasion.1,2
We believe a persuasive moral argument for conducting some research on human embryos can be made.
Such an argument must explicitly and straightforwardly account for the relationships involved in human procreation and its social context. An embryo has moral
standing not so much for what it is (at conception or
later), but because it is the result of procreative activity.
The strong public reaction to the ongoing embryo scandal at the University of California at Irvine, for example, occurred not because embryos were made the objects of medical research, but because they were used
to create babies without either the consent of the ova
providers or disclosure of information about the origins
of the children to the parents now raising them.9 People
have a direct interest in the status and fate of every embryo formed from their gametes, because such embryos
carry their genes and can potentially become their children. In this respect, the embryo is not only a symbol;
it is real. Similarly, society has a direct interest in that

The New England Journal of Medicine
Downloaded from nejm.org at BOSTON UNIVERSITY on December 7, 2021. For personal use only. No other uses without permission.
Copyright © 1996 Massachusetts Medical Society. All rights reserved.

Vol. 334

No. 20

SOUNDING BOARD

embryo, since society has an interest in how its members procreate and how families are created.
Recognizing that the embryo’s moral status derives
not only from a property or cluster of properties it possesses, but also from the interests that potential parents
and society bring to procreation and reproduction,
makes it clearer why creating embryos solely for research purposes is morally problematic. If two people
seek to have a child and create a number of embryos
to help them do so, there can be no doubt that they
hope that at least one of those embryos will become a
child. For most people it is the intention to create a
child that makes the creation of an embryo a moral act.
To create embryos solely for research — or to sell
them, or to use them in toxicity testing — seems morally wrong because it seems to cheapen the act of procreation and turn embryos into commodities. Creating
embryos speciﬁcally for research also puts women at
risk as sources of ova for projects that provide them no
beneﬁt.10
Careless use of language can also undercut moral
arguments. The panel, for example, described a human embryo as “signiﬁcantly smaller than the period
at the end of this sentence.”4 These words suggest that
we should judge an embryo’s value by its size; that it
is, after all, just a speck or dot.11 But describing the period as located “at the end of this sentence” suggests
that periods have value only in relation to words. Periods are related to sentences and conclude them. In
the same way, embryos are valued because of their relationship to the gamete providers, the potential parents, not because of their size. Deliberately creating
embryos that are disconnected from human relationships takes them out of context. Removing them from
the context of human procreation calls for a much better justiﬁcation than the acquisition of potentially important information. Embryos created for procreation,
but ultimately not needed because the procreative
aims of the couple have been reached, do not have this
“manufactured-orphan” status. This argument parallels one used by those who approve of using tissue
from aborted fetuses for research, but many of these
same people would be horriﬁed at the idea that a
woman could become pregnant for the sole purpose of
having an abortion to produce fetal tissue for research
purposes.
Thus, many people, like President Clinton, could approve of research using “spare” embryos created by in
vitro fertilization without approving of the creating of
embryos for that speciﬁc purpose.2,8 Provided with reasonable grounds for distinguishing research on spare
embryos from research on embryos created solely for
the purpose, even the Republican-dominated House of
Representatives might have made the distinction. The
House Appropriations Committee, for example, voted
30 to 23 in July 1995 to bar all federal funding for research on human embryos.12 A proposed amendment to
permit such funding for research on spare embryos
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failed by a tie vote (26–26). It seems plausible that a
more nuanced rationale for this distinction could have
persuaded at least 1 of the 26 members who voted
against the amendment to vote for it.
The moral problem with making embryos for research is that as a society we do not want to see embryos treated as products or as mere objects, for fear
that we will cheapen the value of parenting, risk commercializing procreation, and trivialize the act of procreation. It is society’s moral attitude toward procreation and the interests of those whose gametes are
involved in making the embryos that provide the moral
force behind the restriction or prohibition of the manufacture of embryos for nonprocreative uses. A moral
framework that reduces the matter to an exclusive focus on the intrinsic properties of embryos, ignoring the
interests of those whose gametes make the embryos
and the circumstances under which procreation occurs,
cannot persuade, or even engage, those to whom the
creation of embryos solely for research is morally suspect. Obtaining consent is not enough. A new framework — one that takes relationships seriously — is essential.
THE POLITICS OF ABORTION
An ethical discussion of research on embryos ex utero
need not involve abortion, because no pregnancy is involved. When legally protectable human life begins is
an important issue, but it is one that must be confronted on its own terms. Moreover, embryo research itself
can actually help both to increase the number of pregnancies and to reduce the number of abortions. One
example is preimplantation genetic diagnosis, which
involves the extracorporeal creation of an embryo
through in vitro fertilization, followed by blastomere
removal for genetic diagnosis. Only embryos determined not to be affected by the genetic disorder in
question are then transferred to the uterus.13 Such genetic diagnosis, unlike conventional prenatal diagnosis
(chorionic-villus sampling or amniocentesis), obviates
the need for a woman to decide whether to undergo an
abortion.
A strong case can also be made for the importance
of embryo studies to understanding basic problems of
fertilization and development and improving the effectiveness of in vitro fertilization itself. Research on fetaltissue transplantation did not garner public support
and federal ﬁnancing until supporters persuaded Congress that it might beneﬁt the treatment of major diseases, such as Parkinson’s disease.14 Embryo research
will not receive needed support unless it is linked more
directly to research on fertility. It should be acknowledged, of course, that even those to whom choosing
among “permanent storage,” destruction, and donation
presents no particular ethical problem may nonetheless
reject the idea of research using spare embryos on the
prudential basis that once such research is accepted, research on embryos created speciﬁcally for research is
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inevitable. It is easy to see the force of this version of
the slippery-slope argument,10 but a line can nonetheless be drawn and maintained as long as the rationale
for it is accepted and embryo research addresses questions directly related to infertility.
The country needs clear and consistent rules for research on human embryos, as well as uniform methods
of review. This uniformity cannot be provided by local
institutional review boards, but only by a central review
panel. There is a compelling need for the nationwide
regulation of embryo research, and federal funding of
such research would provide an impetus for such uniform rules.3
Ethics in the public sector cannot transcend politics
completely, because the public sector is the political arena. But for ethical guidelines to survive changes in political power in Washington, they must be grounded on
more than political expediency. When politicians can associate issues of medical ethics with the politics of abortion, they will do so. In politics, the majority vote wins.
In ethics, however, ethical reasoning should prevail: a
vote without a supporting rationale will not be convincing to policy makers in a world where one’s position on
abortion can directly affect one’s political future.
Ethics panels debating an abortion-related issue must
persuasively distinguish their subject from abortion itself and provide a strong ethical reason for the research
and its need for public funding. As the angry response
to President Clinton’s April 10 veto of a ban on “partial-birth” abortion demonstrates, we are nowhere near
a political consensus about abortion.15,16 Unless we are
content to let the politics of abortion bring discussions
of publicly funded medical research to gridlock, we must
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do much better at articulating an ethical basis for abortion-related research.
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